Literature DB >> 11752463

Molecular characteristics of non-small cell lung cancer.

M Nacht1, T Dracheva, Y Gao, T Fujii, Y Chen, A Player, V Akmaev, B Cook, M Dufault, M Zhang, W Zhang, M Guo, J Curran, S Han, D Sidransky, K Buetow, S L Madden, J Jen.   

Abstract

We used hierarchical clustering to examine gene expression profiles generated by serial analysis of gene expression (SAGE) in a total of nine normal lung epithelial cells and non-small cell lung cancers. Separation of normal and tumor, as well as histopathological subtypes, was evident by using the 3,921 most abundant transcript tags. This distinction remained when only 115 highly differentially expressed tags were used. Furthermore, these 115 transcript tags clustered into groups suggestive of the unique biological and pathological features of the different tissues examined. Adenocarcinomas were characterized by high-level expression of small airway-associated or immunologically related proteins, whereas squamous cell carcinomas overexpressed genes involved in cellular detoxification or antioxidation. The messages of two p53-regulated genes, p21(WAF1/CIP1) and 14-3-3final sigma, were consistently underexpressed in the adenocarcinomas, suggesting that the p53 pathway itself might be compromised in this cancer type. Gene expression patterns observed by SAGE were consistent with results obtained by quantitative real-time PCR or cDNA array analyses by using a total of 43 lung tumor and normal samples. Thus, although derived from only a few tissue libraries, gene expression profiles obtained by using SAGE most likely represent an unbiased yet distinctive molecular signature for the most common forms of human lung cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11752463      PMCID: PMC65007          DOI: 10.1073/pnas.261414598

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  48 in total

1.  EST comparison indicates 38% of human mRNAs contain possible alternative splice forms.

Authors:  D Brett; J Hanke; G Lehmann; S Haase; S Delbrück; S Krueger; J Reich; P Bork
Journal:  FEBS Lett       Date:  2000-05-26       Impact factor: 4.124

2.  A gene expression database for the molecular pharmacology of cancer.

Authors:  U Scherf; D T Ross; M Waltham; L H Smith; J K Lee; L Tanabe; K W Kohn; W C Reinhold; T G Myers; D T Andrews; D A Scudiero; M B Eisen; E A Sausville; Y Pommier; D Botstein; P O Brown; J N Weinstein
Journal:  Nat Genet       Date:  2000-03       Impact factor: 38.330

Review 3.  Progress in understanding the molecular pathogenesis of human lung cancer.

Authors:  Y Sekido; K M Fong; J D Minna
Journal:  Biochim Biophys Acta       Date:  1998-08-19

4.  Identification of CDK4 as a target of c-MYC.

Authors:  H Hermeking; C Rago; M Schuhmacher; Q Li; J F Barrett; A J Obaya; B C O'Connell; M K Mateyak; W Tam; F Kohlhuber; C V Dang; J M Sedivy; D Eick; B Vogelstein; K W Kinzler
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

5.  Frequent alternative splicing of human genes.

Authors:  A A Mironov; J W Fickett; M S Gelfand
Journal:  Genome Res       Date:  1999-12       Impact factor: 9.043

6.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.

Authors:  A A Alizadeh; M B Eisen; R E Davis; C Ma; I S Lossos; A Rosenwald; J C Boldrick; H Sabet; T Tran; X Yu; J I Powell; L Yang; G E Marti; T Moore; J Hudson; L Lu; D B Lewis; R Tibshirani; G Sherlock; W C Chan; T C Greiner; D D Weisenburger; J O Armitage; R Warnke; R Levy; W Wilson; M R Grever; J C Byrd; D Botstein; P O Brown; L M Staudt
Journal:  Nature       Date:  2000-02-03       Impact factor: 49.962

7.  Comparison of GSTM polymorphisms and risk for oral cancer between African-Americans and Caucasians.

Authors:  L Y Park; J E Muscat; T Kaur; S P Schantz; J C Stern; J P Richie; P Lazarus
Journal:  Pharmacogenetics       Date:  2000-03

8.  Identification of c-MYC as a target of the APC pathway.

Authors:  T C He; A B Sparks; C Rago; H Hermeking; L Zawel; L T da Costa; P J Morin; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1998-09-04       Impact factor: 47.728

9.  Cluster analysis and display of genome-wide expression patterns.

Authors:  M B Eisen; P T Spellman; P O Brown; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

10.  A small proline-rich protein, spr1: specific marker for squamous lung carcinoma.

Authors:  R Hu; R Wu; J Deng; D Lau
Journal:  Lung Cancer       Date:  1998-04       Impact factor: 5.705

View more
  36 in total

Review 1.  Lung cancer . 3: Fluorescence bronchoscopy: clinical dilemmas and research opportunities.

Authors:  A K Banerjee; P H Rabbitts; J George
Journal:  Thorax       Date:  2003-03       Impact factor: 9.139

Review 2.  [Current morphological diagnosis of malignant lung tumors].

Authors:  K Junker
Journal:  Pathologe       Date:  2006-03       Impact factor: 1.011

3.  Global detection of molecular changes reveals concurrent alteration of several biological pathways in nonsmall cell lung cancer cells.

Authors:  Z Ju; M Kapoor; K Newton; K Cheon; A Ramaswamy; R Lotan; L C Strong; J S Koo
Journal:  Mol Genet Genomics       Date:  2005-10-11       Impact factor: 3.291

4.  A carbazole alkaloid deactivates mTOR through the suppression of rictor and that induces apoptosis in lung cancer cells.

Authors:  Priyajit Chatterjee; Soma Seal; Sandip Mukherjee; Rakesh Kundu; Mantu Bhuyan; Nabin C Barua; Pranab K Baruah; Santi Prasad Sinha Babu; Samir Bhattacharya
Journal:  Mol Cell Biochem       Date:  2015-04-17       Impact factor: 3.396

5.  Characterization of signaling function and expression of HLA class I molecules in medulloblastoma.

Authors:  Courtney Smith; Mariarita Santi; Elisabeth J Rushing; Robert Cornelison; Tobey J MacDonald; Stanislav Vukmanovic
Journal:  J Neurooncol       Date:  2010-09-02       Impact factor: 4.130

6.  Profiling of Hodgkin's lymphoma cell line L1236 and germinal center B cells: identification of Hodgkin's lymphoma-specific genes.

Authors:  Ines Schwering; Andreas Bräuninger; Verena Distler; Julia Jesdinsky; Volker Diehl; Martin-Leo Hansmann; Klaus Rajewsky; Ralf Küppers
Journal:  Mol Med       Date:  2003 Mar-Apr       Impact factor: 6.354

7.  A novel role of HLA class I in the pathology of medulloblastoma.

Authors:  Courtney Smith; Mariarita Santi; Bhargavi Rajan; Elisabeth J Rushing; Mi Rim Choi; Brian R Rood; Robert Cornelison; Tobey J MacDonald; Stanislav Vukmanovic
Journal:  J Transl Med       Date:  2009-07-12       Impact factor: 5.531

8.  Comparison of lung cancer cell lines representing four histopathological subtypes with gene expression profiling using quantitative real-time PCR.

Authors:  Takashi Watanabe; Tomohiro Miura; Yusuke Degawa; Yuna Fujita; Masaaki Inoue; Makoto Kawaguchi; Chie Furihata
Journal:  Cancer Cell Int       Date:  2010-01-21       Impact factor: 5.722

9.  Gene expression profiles from needle biopsies provide useful signatures of non-small cell lung carcinomas.

Authors:  Douglas E Paull; Kevin Kelley; Jazbieh Moezzi; Madhavi Kadakia; Steven J Berberich
Journal:  Biomark Insights       Date:  2007-06-08

Review 10.  Clinical impact of high-throughput gene expression studies in lung cancer.

Authors:  Jennifer Beane; Avrum Spira; Marc E Lenburg
Journal:  J Thorac Oncol       Date:  2009-01       Impact factor: 15.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.